NanoMuG
NanoMuG develops biofunctional drug delivery platforms based on mucin nanoparticles, called Mucosomes, which leverage natural mucoadhesion and biofilm-disrupting properties to improve therapeutic targeting. The technology uses green synthesis from food industry by-products to encapsulate a wide range of bioactive molecules, from small APIs to proteins, for applications in oncology, infectious diseases, and mucosal health.
- Biotechnology
- Drug Discovery & Therapeutics
- Healthcare Technology
- New Materials
Funding
Founders
Product
Problem
Conventional drug delivery systems often suffer from poor targeting, limited mucoadhesion, and inadequate penetration of biological barriers, reducing therapeutic efficacy and increasing side effects. Many existing platforms also rely on synthetic materials and energy-intensive production methods that are neither sustainable nor easily scalable for advanced therapies.
Solution
NanoMuG provides a bioinspired drug delivery platform built on glycosylated mucin nanoparticles, branded as Mucosomes. These nanoparticles harness the natural properties of mucins to enhance mucoadhesion, disrupt biofilms, and enable selective interactions with pathogens through unique glycosylation patterns. The platform combines synthesis, encapsulation, and functionalization into a single streamlined process, reducing waste and boosting production efficiency. Mucosomes can encapsulate a broad spectrum of bioactive molecules, from small-molecule APIs to larger proteins, offering a versatile and scalable solution for pharmaceutical development.
Target Audience
Primary customers are pharmaceutical companies and biotech researchers developing therapies for oncology, infectious diseases, and mucosal health applications who require advanced drug delivery solutions.
Features
- Bioinspired mucin nanoparticles with natural mucoadhesive and biofilm-disrupting capabilities for improved mucosal drug delivery
- Unique mucin glycosylation enables selective targeting of pathogens and specific biological surfaces
- Single-step process integrating synthesis, encapsulation, and functionalization to reduce waste and increase manufacturing efficiency
- Broad cargo compatibility supporting encapsulation of small-molecule APIs, proteins, and other bioactive compounds
- Green synthesis method utilizing food industry by-products for cost-effective, sustainable, and scalable production